ARTICLE | Company News
Schering-Plough pulls Cylatron MAA
March 17, 2009 1:40 AM UTC
EMEA said Schering-Plough (NYSE:SGP) withdrew an MAA for Cylatron peginterferon alfa-2b as an adjuvant treatment for stage III melanoma. According to EMEA, Schering-Plough pulled the application based...